A Daas
Impact in
- Microbiology top 5%
- Microbial infections and disease research
- Bacterial Infections and Vaccines
- Virology top 10%
- Rabies epidemiology and control
Papers in
- Immunology 20
- Biosimilars and Bioanalytical Methods 16
-
- Viral gastroenteritis research and epidemiology 6
- Co-authors
- Dorothea Sesardic (7 shared papers)Randi Winsnes (4 shared papers)Beate Krämer (2 shared papers)K H Buchheit (9 shared papers)Ivo Claassen (2 shared papers)Janet M. Daly (1 shared paper)Coenraad Hendriksen (2 shared papers)Richard Isbrucker (1 shared paper)
- Journals
- Biologicals (2 papers)Vox Sanguinis (1 paper)PubMed (49 papers)
- Partner nations
- BelgiumUnited KingdomGermany
In The Last Decade
A Daas
50 papers receiving 312 citations
Peers
Comparison fields: 5 of 64
- Microbiology 102
- Virology 45
- Endocrinology 41
- Immunology and Allergy 24
- Infectious Diseases 73
Countries citing papers authored by A Daas
This map shows the geographic impact of A Daas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Daas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Daas more than expected).
Fields of papers citing papers by A Daas
This network shows the impact of papers produced by A Daas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Daas. The network helps show where A Daas may publish in the future.
Co-authors
The 25 scholars most cited alongside A Daas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 53 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Collaborative study for validation of a serological potency assay for rabies vaccine (inactivated) for veterinary use. | 2010 | 30 |
| 2 | Establishment of recombinant major allergens Bet v 1 and Phl p 5a as Ph. Eur. reference standards and validation of ELISA methods for their measurement. Results from feasibility studies. | 2012 | 24 |
| 3 | Validation study to evaluate the reproducibility of a candidate in vitro potency assay of newcastle disease vaccines and to establish the suitability of a candidate biological reference preparation. | 2004 | 21 |
| 4 | Collaborative study for the validation of serological methods for potency testing of diphtheria toxoid vaccine (part 2). | 2004 | 21 |
| 5 | Serological assays as alternatives to the Ph Eur challenge test for batch release of tetanus vaccines for human use. | 1999 | 20 |
| 6 | Collaborative study on influenza vaccine clinical trial serology - part 2: reproducibility study. | 2011 | 16 |
| 7 | Collaborative study for the standardisation of the histamine sensitizing test in mice and the CHO cell-based assay for the residual toxicity testing of acellular pertussis vaccines. | 2010 | 15 |
| 8 | Collaborative study for the establishment of a candidate equine influenza subtype 2 American-like strain A/EQ/South Africa/4/03 - horse antiserum biological reference preparation. | 2007 | 15 |
| 9 | Transferability study of CHO cell clustering assays for monitoring of pertussis toxin activity in acellular pertussis vaccines. | 2016 | 14 |
| 10 | Establishment of European pharmacopoeia Mycoplasma reference strains. | 2006 | 13 |
| 11 | Collaborative study for the establishment of the WHO 3(rd) International Standard for Endotoxin, the Ph. Eur. endotoxin biological reference preparation batch 5 and the USP Reference Standard for Endotoxin Lot H0K354. | 2015 | 10 |
| 12 | 2013 | 10 | |
| 13 | Calibration of the Ph. Eur. BRP Batch 3/Mega 2 (US/FDA) standard for human coagulation factor VIII concentrate for use in the potency assay. | 2002 | 10 |
| 14 | Collaborative study for establishment of the European Pharmacopoeia BRP batch 1 for diphtheria toxin. | 2003 | 10 |
| 15 | Collaborative study for establishment of a European Pharmacopoeia Biological Reference Preparation (BRP) for B19 virus DNA testing of plasma pools by nucleic acid amplification technique. | 2004 | 9 |
| 16 | A Vero cell method for potency testing of diphtheria vaccines. | 2002 | 9 |
| 17 | Establishment of batch 4 of the Biological Reference Preparation (BRP) for rabies vaccine (inactivated) for veterinary use. | 2004 | 8 |
| 18 | Collaborative study for the establishment of erythropoietin BRP batch 3. | 2007 | 7 |
| 19 | Feasibility study to evaluate the correlation between results of a candidate in vitro assay and established in vivo assays for potency determination of Newcastle disease vaccines. | 2003 | 7 |
| 20 | Collaborative study for the establishment of a European Pharmacopoeia Biological Reference Preparation for pertussis toxin--Part 1. | 2001 | 6 |
About A Daas
A Daas is a scholar working on Immunology, Infectious Diseases, Radiology, Nuclear Medicine and Imaging, Molecular Biology and Epidemiology, having authored 53 papers that have together received 345 indexed citations. Recurring topics across this work include Biosimilars and Bioanalytical Methods (16 papers), Monoclonal and Polyclonal Antibodies Research (11 papers), Diphtheria, Corynebacterium, and Tetanus (10 papers), Pharmaceutical studies and practices (7 papers), Viral gastroenteritis research and epidemiology (6 papers), Hepatitis Viruses Studies and Epidemiology (4 papers), Bacterial Infections and Vaccines (4 papers) and Microbial infections and disease research (4 papers). The work is most often cited by research in Microbiology (102 citations), Virology (45 citations), Endocrinology (41 citations), Immunology and Allergy (24 citations) and Infectious Diseases (73 citations). A Daas has collaborated with scholars based in Belgium, United Kingdom and Germany. Frequent co-authors include Dorothea Sesardic, Randi Winsnes, Beate Krämer, K H Buchheit, Ivo Claassen, Janet M. Daly, Coenraad Hendriksen, Richard Isbrucker, G Rautmann and Adrian F. Bristow. Their work appears in journals such as Biologicals, Vox Sanguinis and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.